This medication is an antidiabetic (sodium glucose co-transporter 2 (SGLT2) inhibitor), prescribed for type 2 diabetes mellitus along with diet and exercise. For patients with type 2 diabetes along with diabetic kidney disease, physicians should consider using an SGLT2 inhibitor when the eGFR is at or above 30, especially with albuminuria above 300 mg/g, to lower renal and CV risk as per A.D.A recommendations.
Contraindicated in patients with severe kidney impairment, ESRD, or on dialysis and known hypersensitivity.
PO- The recommended initial dose is 100 mg once daily.
It comes as a tablet to take by mouth, should be taken before the first meal of the day.
• Caution should be exercised in patients with history of kidney or liver problems, any allergy, who are taking other medications, elderly, during pregnancy and breastfeeding.
• Monitor kidney functions, potassium levels regularly while taking this medication; correct hypovolaemia (decreased blood volume) in patients with kidney impairment, the elderly and in patients with low systolic blood pressure.
• Patient may develop with increased risk of genital mycotic infections and increased LDL; if it is so consult with your healthcare provider.
• Most Common : Female genital mycotic infections, urinary tract infection and increased urination.
• Gastrointestinal : Increased thirst, constipation, nausea and vomiting.
Avoid excess dosage.
Store at 25°C.
Subscribe to our Free Newsletters!